Most COVID-19 treatment guidelines currently recommend tocilizumab in combination with dexamethasone in critically ill patients who are exhibiting rapid respiratory decompensation.

Signals were broadly positive for months, but never definitive: the tocilizumab story / Cozzi-Lepri, Alessandro; Smith, Colette; Mussini, Cristina. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 28:3(2022), pp. 371-374. [10.1016/j.cmi.2021.10.018]

Signals were broadly positive for months, but never definitive: the tocilizumab story

Mussini, Cristina
2022

Abstract

Most COVID-19 treatment guidelines currently recommend tocilizumab in combination with dexamethasone in critically ill patients who are exhibiting rapid respiratory decompensation.
2022
28
3
371
374
Signals were broadly positive for months, but never definitive: the tocilizumab story / Cozzi-Lepri, Alessandro; Smith, Colette; Mussini, Cristina. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 28:3(2022), pp. 371-374. [10.1016/j.cmi.2021.10.018]
Cozzi-Lepri, Alessandro; Smith, Colette; Mussini, Cristina
File in questo prodotto:
File Dimensione Formato  
PIIS1198743X21006200.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 240.57 kB
Formato Adobe PDF
240.57 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1256049
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact